Kania A, Klein R. Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat Rev Mol Cell Biol. 2016;17:240–56.
Article CAS PubMed Google Scholar
Miao H, Wang B. EphA receptor signaling-complexity and emerging themes. Semin Cell Dev Biol. 2012;23:16–25.
Article CAS PubMed Google Scholar
Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010;10:165–80.
Article CAS PubMed PubMed Central Google Scholar
Boyd AW, Bartlett PF, Lackmann M. Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov. 2014;13:39–62.
Article CAS PubMed Google Scholar
Charmsaz S, Boyd AW. Eph receptors as oncotargets. Oncotarget. 2017;8:81727–8.
Article PubMed PubMed Central Google Scholar
Barquilla A, Pasquale EB. Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharm Toxicol. 2015;55:465–87.
Lindberg RA, Hunter T. cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol Cell Biol. 1990;10:6316–24.
CAS PubMed PubMed Central Google Scholar
Wykosky J, Debinski W. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res. 2008;6:1795–806.
Article CAS PubMed PubMed Central Google Scholar
Brantley-Sieders DM, Chen J. Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis. 2004;7:17–28.
Article CAS PubMed Google Scholar
Chen J, Song W, Amato K. Eph receptor tyrosine kinases in cancer stem cells. Cytokine Growth Factor Rev. 2015;26:1–6.
Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, et al. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol. 2009;174:1492–503.
Article CAS PubMed PubMed Central Google Scholar
Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, et al. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate. 1999;41:275–80.
Article CAS PubMed Google Scholar
Kurose H, Ueda K, Kondo R, Ogasawara S, Kusano H, Sanada S, et al. Elevated expression of EPHA2 is associated with poor prognosis after radical prostatectomy in prostate cancer. Anticancer Res. 2019;39:6249–57.
Article CAS PubMed Google Scholar
Sachdeva A, Hart CA, Kim K, Tawadros T, Oliveira P, Shanks J, et al. Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. Br J Cancer. 2022;127:1254–62.
Article CAS PubMed PubMed Central Google Scholar
Bartley TD, Hunt RW, Welcher AA, Boyle WJ, Parker VP, Lindberg RA, et al. B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature. 1994;368:558–60.
Article CAS PubMed Google Scholar
Himanen JP, Yermekbayeva L, Janes PW, Walker JR, Xu K, Atapattu L, et al. Architecture of Eph receptor clusters. Proc Natl Acad Sci USA. 2010;107:10860–5.
Article CAS PubMed PubMed Central Google Scholar
Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell. 2009;16:9–20.
Article CAS PubMed PubMed Central Google Scholar
Yang NY, Fernandez C, Richter M, Xiao Z, Valencia F, Tice DA, et al. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Cell Signal. 2011;23:201–12.
Article CAS PubMed Google Scholar
Herath NI, Spanevello MD, Doecke JD, Smith FM, Pouponnot C, Boyd AW. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis. Eur J Cancer. 2012;48:753–62.
Article CAS PubMed Google Scholar
Miao H, Burnett E, Kinch M, Simon E, Wang B. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol. 2000;2:62–9.
Article CAS PubMed Google Scholar
Noberini R, Rubio de la Torre E, Pasquale EB. Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. Cell Adh Migr. 2012;6:102–12.
Article PubMed PubMed Central Google Scholar
Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol. 2001;3:527–30.
Article CAS PubMed Google Scholar
Huang X, Wu D, Jin H, Stupack D, Wang JY. Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol. 2008;183:711–23.
Article CAS PubMed PubMed Central Google Scholar
Carter N, Nakamoto T, Hirai H, Hunter T. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol. 2002;4:565–73.
Article CAS PubMed Google Scholar
Vreeken D, Zhang H, van Zonneveld AJ, van Gils JM. Ephs and Ephrins in adult endothelial biology. Int J Mol Sci. 2020;21:5623.
Article CAS PubMed PubMed Central Google Scholar
Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, et al. ADAM12-cleaved ephrin-A1 contributes to lung metastasis. Oncogene. 2014;33:2179–90.
Article CAS PubMed Google Scholar
Ieguchi K, Maru Y. Roles of EphA1/A2 and ephrin-A1 in cancer. Cancer Sci. 2019;110:841–8.
Article CAS PubMed PubMed Central Google Scholar
Larson J, Schomberg S, Schroeder W, Carpenter TC. Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol Lung Cell Mol Physiol. 2008;295:L431–9.
Article CAS PubMed PubMed Central Google Scholar
Prasad TS, Kandasamy K, Pandey A. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol. 2009;577:67–79.
Article CAS PubMed Google Scholar
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinforma. 2016;54:1.30.31–1.30.33.
UniProt C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523–31.
留言 (0)